ECM14 Antibody

What is ECM14 and why is it significant for antibody development?

ECM14 is a carboxypeptidase-like pseudoenzyme belonging to the M14 family of metallocarboxypeptidases. It is widely distributed within the ascomycete branch of the fungal kingdom, with a structure similar to the A/B subfamily of MCPs . Despite lacking enzymatic activity, ECM14 is conserved across fungi, suggesting important biological functions that make it a valuable target for antibody-based research. Recent studies suggest roles in vesicle-mediated transport and aggregate invasion in fungi, processes that have been selected against in modern laboratory strains of S. cerevisiae .

What structural features of ECM14 are important for antibody targeting?

ECM14 exists in multiple forms that should be considered when developing antibodies:

• A pro-form observed as a doublet at approximately 45 kDa

• A mature form observed as a doublet at approximately 35 kDa

• N-glycosylation at two predicted surface sites, creating the doublet pattern observed in Western blots

The protein undergoes processing by an endopeptidase, converting the pro-form to the mature form. This processing is important to consider when designing antibodies for specific research applications.

What epitopes of ECM14 should be targeted for antibody development?

When developing antibodies against ECM14, researchers should consider:

• The key active site substitutions that make ECM14 a pseudoenzyme (N144D, R145H, and most notably, E270K using bovine CPA1 numbering)

• Targeting the pro-domain to specifically detect the unprocessed form

• Targeting the mature domain to detect both forms

• Avoiding N-glycosylation sites which might interfere with antibody binding

• Targeting conserved regions for cross-species reactivity within ascomycetes

How can researchers validate the specificity of ECM14 antibodies?

Validation of ECM14 antibodies should include:

• Testing reactivity against wild-type versus ecm14Δ strains

• Comparing antibody binding with recombinant ECM14-His6 protein expressed in controlled systems

• Confirming detection of both glycosylated and deglycosylated forms through EndoH treatment

• Verifying antibody recognition of both pro-domain and mature forms at expected sizes

• Testing for cross-reactivity with related carboxypeptidases

How can ECM14 antibodies improve understanding of protein processing mechanisms?

ECM14 antibodies can enhance studies of protein processing by:

• Tracking the conversion of pro-ECM14 (45 kDa) to mature ECM14 (35 kDa) under different conditions

• Examining how N-glycosylation affects processing, as observed in the doublet patterns resolved by EndoH treatment

• Identifying the endopeptidase responsible for processing through co-immunoprecipitation studies

• Investigating regulatory mechanisms that control ECM14 maturation in different fungal growth phases

What approaches can be used to study ECM14's evolutionary relationships using antibodies?

Researchers can explore ECM14 evolution with antibodies by:

• Developing antibodies against highly conserved regions shared across fungal species

• Examining protein conservation between ascomycetes and the sister clade of CP-like proteins from Basidiomycota identified in phylogenetic analyses

• Comparing epitope conservation in sequences with different patterns of active site substitutions (Arg127Tyr, His196Arg, and Glu270His found in some Basidiomycota)

• Analyzing processing patterns across evolutionarily distinct species

What protein extraction methods optimize ECM14 detection in fungal samples?

For optimal ECM14 extraction and detection:

• Include methods for capturing secreted forms, as ECM14 is known to be secreted from cells

• Consider cell wall digestion techniques for complete extraction from yeast cells

• Use appropriate detergents for membrane-associated forms

• Include protease inhibitors to prevent degradation of pro or mature forms

• Account for N-glycosylation when interpreting band patterns in Western blots

How can ECM14 antibodies be used to investigate subcellular localization?

Researchers can study ECM14 localization by:

• Employing immunofluorescence microscopy with ECM14 antibodies to visualize distribution in intact cells

• Using immunogold electron microscopy for higher resolution localization

• Performing cell fractionation followed by immunoblotting to determine which cellular compartments contain ECM14

• Examining colocalization with secretory pathway markers, given ECM14's status as a secreted protein

How can ECM14 antibodies complement synthetic lethal screens?

ECM14 antibodies can enhance synthetic lethal approaches (as described in the literature ) by:

• Confirming protein expression levels in strains carrying plasmid-borne ECM14

• Examining ECM14 processing or localization in synthetic lethal mutants

• Identifying protein interaction differences in synthetic lethal backgrounds

• Validating phenotypes observed in the red/white colony assay used in synthetic lethal screens with EMS mutagenesis

What techniques can be used to study the relationship between ECM14 and cell wall integrity?

Given ECM14's proposed function in the extracellular matrix , researchers can:

• Visualize ECM14 distribution relative to cell wall components using immunofluorescence

• Examine ECM14 expression and localization during cell wall stress conditions

• Analyze ECM14 processing in cell wall integrity pathway mutants

• Investigate potential ECM14 interactions with other extracellular matrix components

How do ECM14 expression patterns compare across different fungal species?

Researchers can use cross-reactive antibodies to:

• Compare ECM14 expression levels across diverse fungal species

• Examine differences in processing patterns between species

• Identify species-specific post-translational modifications

• Correlate ECM14 expression with phenotypic differences in aggregate invasion capability

What experimental approaches can identify ECM14 interaction partners?

To study ECM14 protein interactions:

• Perform co-immunoprecipitation using ECM14 antibodies to identify binding partners

• Use proximity labeling approaches combined with immunoprecipitation

• Conduct in situ proximity ligation assays to visualize interactions in intact cells

• Combine with mass spectrometry techniques similar to those used in phosphoproteomic studies

What factors might affect ECM14 antibody detection sensitivity?

Several factors can impact detection:

• N-glycosylation masking epitopes (as demonstrated by the effect of EndoH treatment)

• Processing state (pro vs. mature) affecting epitope availability

• Expression levels varying with growth conditions or strain background

• Extraction efficiency differences between cellular compartments and secreted fractions

How can researchers optimize western blotting protocols for ECM14 detection?

Based on published ECM14 research approaches :

• Use appropriate percentage gels to resolve both the 45 kDa pro-form and 35 kDa mature form

• Consider parallel samples with and without EndoH treatment to distinguish glycosylation patterns

• Include positive controls such as recombinant ECM14-His6 expressed from plasmids like pEMBLyEx4

• Optimize transfer conditions for glycoproteins if blotting efficiency is low

How might ECM14 antibodies contribute to understanding fungal pathogenicity?

ECM14 antibodies could advance pathogenicity research by:

• Comparing ECM14 expression and processing between pathogenic and non-pathogenic fungi

• Investigating ECM14's role in aggregate invasion, which may relate to pathogenicity mechanisms

• Examining ECM14 interactions with host tissues during infection

• Evaluating ECM14 as a potential biomarker for fungal infections

What proteomics approaches can be combined with ECM14 antibodies for comprehensive analysis?

Researchers can integrate ECM14 antibodies with advanced proteomics by:

• Using techniques similar to phosphoproteomic assays described in contemporary research

• Performing immunoprecipitation followed by mass spectrometry to identify post-translational modifications

• Combining with techniques like the GloSensor cAMP reporter systems to study downstream signaling

• Integrating with CRISPR/Cas9 gene editing approaches to study ECM14 function